Kaia Health Joins Sword Health

MUNICH — [January 28, 2026] — Kaia Health, a pioneer in digital therapy for musculoskeletal (MSK) and pulmonary care, today announced that it has been acquired by Sword Health. The acquisition marks the culmination of Kaia’s journey as a standalone innovator and the beginning of a powerful new chapter within the world’s leading AI Health company.

Since its founding, Kaia Health has been driven by a singular mission: to make high-quality, evidence-based care accessible to anyone, anywhere. From establishing a leading presence in Germany’s digital health reimbursement pathway to reaching millions of members through U.S. employers and other healthcare partnerships, Kaia has redefined how people can manage chronic conditions.

“Joining Sword Health represents a powerful next chapter for the mission we’ve spent over a decade building.” said Adam Pellegrini, CEO of Kaia Health. “We share a common vision: using technology to democratize access to high-quality care . By becoming part of Sword, we can significantly expand our impact for the millions of patients who rely on Kaia today.”

In the United States, Kaia Health has enabled access to digital MSK care for millions of members.. Following the acquisition, these populations will be further supported by Sword Health’s AI Care platform, ensuring uninterrupted care while benefiting from Sword’s industry-leading outcomes, engagement, and cost efficiency.

In Europe, Kaia Health has established a strong presence through Germany’s digital health reimbursement pathway, which provides access to digital therapies for more than 70 million people. As part of Sword Health, Kaia’s foundation in Germany will serve as a key pillar for further expansion across Europe, reinforcing a shared commitment to working within national health systems to deliver scalable, evidence-based care.

The acquisition reflects the complementary strengths of both organizations: Kaia’s European market presence and strong technology foundations, combined with Sword Health’s advanced AI models, global scale, and expanding portfolio across physical, women’s, and mental health.

Hogan Lovells International LLP served as lead legal counsel to Kaia Health for the transaction.

About Kaia Health

Kaia Health is a digital therapeutics company delivering evidence-based care for musculoskeletal and pulmonary conditions. Through clinically validated digital programs, Kaia helps people manage pain, improve function, and enhance quality of life while reducing healthcare costs. Kaia works with employers, payers, and public health systems, including Germany’s digital health reimbursement framework, to make high-quality care accessible to millions worldwide.

About Sword Health

Sword Health is shifting healthcare to an AI-first model that makes world-class care available anytime, anywhere, at scale, while reducing costs for payers, self-insured employers, national health systems and other healthcare organizations. Starting with physical health and expanding into women’s and mental health, Sword is building the AI to heal the world.

Since 2020, more than 700,000 members across three continents have completed 10 million AI sessions, helping Sword’s 1,000+ enterprise clients avoid over $1 billion in unnecessary healthcare costs. Backed by 43 clinical studies and over 45 patents, Sword Health has raised more than $500 million from leading investors, including Khosla Ventures, General Catalyst, Transformation Capital, and Founders Fund. Learn more at www.swordhealth.com.